HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Quest for clinically meaningful PFS benefit an ‘imperfect science’
-
- I’d like to agree with you … but then we’d both be wrong! Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
- FDA approves Avastin for treatment of advanced cervical cancer
- Lymphovascular invasion, regression novel prognostic factors in thin melanomas
- Cetuximab plus chemotherapy yielded worse outcomes in metastatic colorectal cancer
- Adjuvant radiation therapy improved survival in diffuse-type gastric cancer
- BEACOPP extended survival in low-risk Hodgkin’s lymphoma
- Study reveals discordance between HER-2 testing methodologies
- Trebananib plus paclitaxel extended PFS in recurrent epithelial ovarian cancer
-
- Gemtuzumab ozogamicin plus chemotherapy extended OS in AML
- Long-term aspirin use reduced risk for cancer, cardiovascular events
- Childhood cancer survivors at long-term risk for infection-associated mortality
- Enzalutamide improved health-related quality of life in prostate cancer
- Few oncologists consistently provide survivorship care plans to patients
- H. pylori eradication reduced gastric cancer incidence
- HPV vaccination not linked to VTE
- HPV vaccination not tied to risky sexual behavior
-
- IDH mutation status predicted chemoradiation benefit in oligodendroglial tumors
- Long-term central venous catheter use increased infection risk in older patients with cancer
- Men with short life expectancies often undergo aggressive prostate cancer treatment
- MicroRNA signature classifier may reduce false positives in lung cancer
- Newborn screening identified higher incidence of SCID
- PFS similar after laparoscopic open surgery for locally advanced rectal cancer
- Radiation superior to chemotherapy in Merkel cell carcinoma
- Surgery remains ‘gold standard’ for basal cell carcinoma
-
- TBI delivery varies widely across institutions
- Axitinib active in advanced thyroid cancer
- Blood, saliva testing may predict recurrence of HPV-related head and neck cancers
- Doxepin rinse reduced radiotherapy-associated oral mucositis
- Pediatric hematology/oncology society recognizes CHOP physician
- St. Jude announces faculty appointments
- Cancer center appoints associate director
- Salvage treatment conferred favorable outcomes in early-stage breast cancer
-
- Angelina Jolie’s preventive mastectomy doubled one center’s referrals for genetic testing
- Local treatment type affected survival of women with stage I breast cancer
- Worry, lack of knowledge influenced decision to undergo contralateral prophylactic mastectomy
- Late axillary recurrence infrequent after negative SLNB